- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Infographic: Where Is Diabetes Care Headed?
An infographic that looks at 3 factors impacting diabetes care, based on the keynote speech from Patient-Centered Diabetes Care 2015 from Robert A. Gabbay, MD, PhD, of Joslin Diabetes Center.
During his keynote speech at Patient-Centered Diabetes Care (PCDC) 2015, Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center and editor in chief of Evidence-Based Diabetes Management, provided an overview of the programs at Joslin and the care models being implemented to improve patient health in the long term.
The keynote speaker for PCDC 2016, held April 7-8 in Teaneck, NJ, will be Lonny Reisman, MD, the founder and chief executive officer of HealthReveal. PCDC brings together providers, payers, and leaders from across the healthcare landscape to share ideas on care delivery, reimbursement, and other "real-world" issues in diabetes care. The 2016 meeting will feature new sessions on obesity and the use of technology in health management.
Learn more and register now for a discounted price.
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
